Top compounds associated with response to BZW2


Feature Type Standardized
Nominal ANOVA
mRNA darinaparsin CTRPv2 pan-cancer AAC -0.12 0.02
mRNA Imatinib GDSC1000 pan-cancer AAC 0.12 0.02
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.084 0.02
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.085 0.02
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.088 0.02
mRNA CIL55A CTRPv2 pan-cancer AAC 0.12 0.02
mRNA AZD6482 CTRPv2 pan-cancer AAC 0.086 0.02
mRNA GSK-650394 GDSC1000 pan-cancer AAC 0.081 0.02
mRNA SNS-032 CTRPv2 pan-cancer AAC 0.083 0.02
mRNA KIN001-236 GDSC1000 pan-cancer AAC -0.076 0.02
Download CSV